source
- Revolution Medicines threatens lawsuit against Erasca over RAS drug patent and efficacy claimsEarlier this month a newly announced cancer therapy generated strong interest from patients and investors. The drug, which targets the RAS pathway, was highlighted for its potential impact on oncol…
- Insider explains the true purpose behind prior authorizations in U.S. health insuranceThe STAT+ newsletter article by Bob Herman reports on an interview with Archelle Georgiou, who previously worked at the nation’s largest health insurer and was involved in efforts to curb prior aut…